Symmetry Medical, Inc. (SMA) Misses Q4 EPS by 3c; Guides FY12 adj.-EPS

February 23, 2012 7:55 AM EST
Symmetry Medical, Inc. (NYSE: SMA) reported Q4 EPS of $0.01, $0.03 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $84.5 million versus the consensus estimate of $80.8 million.

Symmetry Medical, Inc. sees FY2012 EPS of $0.55-$0.65, versus the consensus of $0.56.

For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings